Nerve signal
A nerve normally releases a chemical messenger called acetylcholine to signal a muscle to contract.
“Botox” is commonly used as shorthand for wrinkle-relaxing injections. Botox® itself is a brand name for a preparation of botulinum toxin type A — a prescription-only medicine.
In aesthetic medicine, carefully selected doses can reduce specific muscle activity that contributes to dynamic facial lines. The effect is temporary and does not add volume to the face.
Important: This page is educational and does not advertise a prescription-only medicine. Any prescription treatment can only be considered following an appropriate clinical assessment and confirmation of medical suitability.
Botulinum toxin is a neurotoxin protein. Purified, precisely dosed preparations of botulinum toxin type A have long been used in medicine for a range of conditions involving excessive muscle activity and, in some situations, gland activity.
In aesthetic practice, very small quantities may be placed into selected facial muscles to temporarily reduce their activity.
This can soften the appearance of lines created or accentuated by repeated facial expression.
Facial expression depends on communication between nerves and muscles. Botulinum toxin temporarily alters part of that communication in the muscle being treated.
A nerve normally releases a chemical messenger called acetylcholine to signal a muscle to contract.
A carefully measured amount is placed into selected muscle tissue following assessment of facial movement.
Release of the nerve messenger is temporarily reduced, so the targeted muscle contracts less strongly.
With less repeated folding of the overlying skin, expression-related lines can appear softer.
Not every wrinkle is produced in the same way. This is one reason a facial assessment matters.
These appear or deepen when a muscle contracts — for example when you frown, squint, smile or raise your eyebrows.
Because muscle activity is an important part of their formation, these are the lines most directly influenced by a wrinkle-relaxing treatment.
These remain visible when the face is at rest. They can reflect repeated movement over time together with changes in collagen, elasticity, sun exposure and facial structure.
Reducing muscle activity may soften some static lines, but established lines may also require time or a different skin-quality approach.
No. Completely eliminating facial movement is not necessarily the objective.
A contemporary approach considers the balance between muscles, your facial anatomy, the strength of your expressions and how much movement you would personally like to retain.
At Santi, our preference is generally for a conservative, natural-looking result rather than treating every visible line simply because it exists.
Vertical “11” lines between the eyebrows associated with activity of the glabellar muscles.
Horizontal lines associated with raising the eyebrows. Forehead and brow movement need to be assessed together.
Expression lines around the outer eye that become particularly visible during smiling and squinting.
Fine expression lines that can appear across the upper sides of the nose.
In selected cases, activity of the DAO muscles can contribute to a downward pull at the mouth corners.
Selected platysmal muscle activity may be assessed where prominent vertical neck bands are a concern.
Botulinum toxin was used medically long before its widespread aesthetic use. Different medical indications require their own assessment, dosing and treatment protocols.
The masseter muscles may be assessed in selected patients with jaw clenching or bruxism.
Botulinum toxin type A can be used under specific medical protocols for selected patients with chronic migraine.
Reducing signalling to sweat glands can be useful in selected cases of excessive sweating.
Your clinician reviews relevant medical conditions, medication, allergies, previous treatment and other factors that could affect suitability.
You may be asked to frown, smile, squint and raise your eyebrows so that muscle strength and interaction can be assessed.
We discuss what actually bothers you and how much movement you want to retain rather than assuming that every line needs treatment.
Where a prescription-only treatment is being considered, it can only proceed when an appropriate prescriber has assessed you and confirmed that treatment is suitable.
The change is not instantaneous. Individual response varies, so these timings are approximate.
Small pin-pricks, slight redness or tiny raised areas may be visible briefly.
A reduction in the strength of the targeted muscle movement may begin to become noticeable.
The treatment is generally assessed once the effect has had time to settle.
The effect is temporary. Muscle activity gradually returns as the treatment wears off.
Both are injectable treatments, but they do fundamentally different things.
| Botulinum toxin | Dermal filler | |
|---|---|---|
| Primary action | Temporarily reduces selected muscle activity | Adds or restores selected volume and structural support |
| Best known for | Dynamic expression lines | Volume, contour and selected folds or hollows |
| Adds volume? | No | Yes |
| Immediate effect? | No — develops over several days | Structural change is generally visible immediately, with swelling settling afterwards |
| Permanent? | No | No — longevity depends on product, area and individual |
| Learn more | Botox educational hub → | Dermal filler guide → |
Repeated facial movement contributes to the formation of some expression lines. Reducing repeated contraction can therefore reduce the folding of the skin while the treatment is active.
That does not mean everyone should begin treatment at a particular age, nor does it guarantee that wrinkles will never develop.
Muscle strength, facial anatomy, skin quality, sun exposure, genetics and personal preference are all more useful considerations than treating simply because someone has reached their twenties, thirties or forties.
For some people, skincare, SPF or a skin-quality treatment may be more relevant than a prescription injectable.
Suitability is individual. Treatment may be inappropriate or need to be postponed depending on your medical history and circumstances.
They are not. One alters selected muscle activity; the other principally provides volume or structural support.
No. Anatomy, muscle strength, indication and treatment goals vary considerably between individuals.
Not necessarily. Preserving appropriate expression can be an important part of treatment planning.
The effect is temporary. If you stop having treatment, muscle activity gradually returns towards its untreated state.
No. The effect of botulinum toxin type A is temporary. Muscle activity gradually returns as the effect wears off.
Duration varies according to the treatment area, dose, muscle activity, product and individual response. Aesthetic effects are commonly measured in months rather than years.
The effect gradually wears off and activity returns to the treated muscles. Your face does not suddenly become worse because you have stopped treatment.
That is not necessarily the objective. Dose and placement can be planned to reduce selected muscle activity while retaining appropriate facial expression.
A very fine needle is used and many people describe the sensation as a brief pin-prick. Sensitivity varies by person and treatment area.
Early changes may become noticeable within several days, with the effect generally assessed once it has settled at around two weeks.
“Baby Botox” is an informal term generally used to describe a conservative or lower-dose approach. It is not a different class of medicine. Dose and placement still need to be individually assessed.
In selected patients, the masseter muscles can be assessed where bruxism or jaw clenching is a concern. This is different from treating upper-face expression lines and requires its own clinical assessment.
Botulinum toxin type A has recognised medical use under specific protocols for selected patients with chronic migraine. Migraine treatment is a medical pathway rather than simply an extension of cosmetic forehead treatment.
No. This is educational information about botulinum toxin and aesthetic medicine. Botulinum toxin type A is a prescription-only medicine and any treatment decision requires an appropriate clinical assessment.
Our main consultation and educational resource for botulinum toxin treatments.
Explore the hub →What people mean by a lighter, conservative approach to wrinkle-relaxing treatment.
Read the guide →An educational guide to the masseter muscle, jaw tension and facial shape.
Read the guide →How excessive masseter activity can relate to clenching, jaw tension and teeth grinding.
Read the guide →What to expect after treatment, what's normal and when to contact the clinic.
Read aftercare →Our medical information pathway for chronic migraine assessment.
Read the guide →Information about excessive sweating and clinical assessment.
Read the guide →Understand how fillers differ from treatments that temporarily reduce muscle activity.
Explore fillers →A consultation allows us to assess your facial movement, medical history and goals and explain whether a prescription treatment — or a different approach — is appropriate.
Educational information only. Botulinum toxin type A is a prescription-only medicine in the UK. Treatment can only be considered following an appropriate clinical assessment. Santi London · 33 Thurloe Street · South Kensington · London SW7 2LQ.
WhatsApp us